The Next Bristol/ImClone? “Standstill” Provisions Complicate Other Deals

Roche and Bristol-Myers Squibb have everyone wondering who will be the next company to buy out its biotech partner

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet